
Omnia Bio is a technology-focused, global cell and gene therapy CDMO that specializes in manufacturing gene-modified cell therapies and viral vectors. With a strong emphasis on automation and artificial intelligence within a Good Manufacturing Practices (GMP) environment, Omnia Bio offers comprehensive services from preclinical to commercial manufacturing. Strategically located in Hamilton, Ontario, and backed by over a decade of expertise from CCRM, the company is positioned to meet the surging global demand for cell and gene therapy manufacturing. Omnia Bio's focus on immune cell-based therapies, induced pluripotent stem cell therapies, and lentiviral vectors allows it to drive advancements in the field, ensuring that transformative treatments reach patients effectively.

Omnia Bio is a technology-focused, global cell and gene therapy CDMO that specializes in manufacturing gene-modified cell therapies and viral vectors. With a strong emphasis on automation and artificial intelligence within a Good Manufacturing Practices (GMP) environment, Omnia Bio offers comprehensive services from preclinical to commercial manufacturing. Strategically located in Hamilton, Ontario, and backed by over a decade of expertise from CCRM, the company is positioned to meet the surging global demand for cell and gene therapy manufacturing. Omnia Bio's focus on immune cell-based therapies, induced pluripotent stem cell therapies, and lentiviral vectors allows it to drive advancements in the field, ensuring that transformative treatments reach patients effectively.
About OmniaBio:
OmniaBio Inc. is a technology-driven, global CDMO specializing in cell and gene therapies, with a mission to transform biomanufacturing with AI and automation. Located at McMaster Innovation Park in Hamilton, Ontario, OmniaBio leverages over a decade of expertise in regenerative medicine and advanced therapies developed in partnership with CCRM. Committed to digital transformation, OmniaBio integrates automation, robotics, and artificial intelligence into its operations to drive efficiency, enhance quality, and increase throughput. This innovative approach supports end-to-end CDMO services—from development through GMP manufacturing and scale-up—helping clients accelerate the path to market for transformative treatments. OmniaBio focuses on immune cell-based therapies, induced pluripotent stem cell therapies, and lentiviral vectors, positioning itself as a leader in advancing and maturing cell and gene therapy manufacturing. With a strategic vision to meet the surging global demand, OmniaBio aims to enable broad access to cutting-edge therapies worldwide.
Visit www.omniabio.com to learn more.
Position Summary
The Project Manager will lead cross-functional teams in a Biotech, Pharma, and/or CDMO environment, managing projects from technology transfer through routine manufacturing for both clinical and commercial assets. This role is responsible for delivering projects in alignment with the Scope of Work, managing change orders and amendments to maintain contract accuracy throughout the project lifecycle, and tracking key project metrics.
As a Project Manager at OmniaBio, you will leverage your expertise in project, client, and contract management to deliver best-in-class, customized services for clinical study manufacturing. You will oversee project scope, budget, timelines, and resource planning to ensure successful execution of client-requested services, including fee-for-service contract manufacturing and other offerings for cell and gene therapy and regenerative medicine clients. Projects will primarily support Phase I/II/III clinical studies and commercial products.
Key Responsibilities:
Client Management & Engagement
Project Management & Reporting
Cross-Functional Team Leadership
General Responsibilities
Requirements
Preferred Qualifications
OmniaBio is a developing organization and represents a fluid working environment. Flexibility and adaptability are essential, and duties will be influenced by the needs of the organization.
Applicants must be legally eligible to work in Canada.
An applicant’s compensation package is finalized once the interview process is concluded and accounts for the nature of the role as well as the experience, competencies (job knowledge, skills and abilities) of the applicant and internal equity.
OmniaBio is committed to accessibility, diversity, and equal opportunity. Requests for accommodation can be made at any stage of the recruitment process, providing the applicant has met the bona fide requirements for the open position. Applicants should make their requirements known once contacted to schedule an interview, or when the job offer has been made.